IP Verse

Elkington And Fife patent opposition analysis

The comprehensive analysis of Elkington And Fife opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Stay updated with the latest patent oppositions filed by Elkington And Fife

Patent Number	Title	Applicant	Opposition Date
EP3897646	Pharmaceutical Composition For The Treatment Of Pulmonary Arterial Hypertension	ACTELION PHARMACEUTICALS	Feb 21, 2025
EP3897646	Pharmaceutical Composition For The Treatment Of Pulmonary Arterial Hypertension	ACTELION PHARMACEUTICALS	Feb 7, 2025
EP4054620	Glp-1 Receptor Agonists In Dementia	NOVO NORDISK	Feb 7, 2025
EP3908684	Producing Etched Structures Made Of A Steel Material	MICROMETAL	Jan 24, 2025
EP4056176	Methods Of Reducing The Risk Of Cardiovascular Events In A Subject	AMARIN PHARMACEUTICALS IRELAND	Jan 24, 2025
EP3335707	Combinations Of A Muscarinic Receptor Antagonist And A Beta-2 Adrenoreceptor Agonist	GLAXO GROUP	Jan 17, 2025
EP3090730	Novel Pharmaceutical Composition	NOVARTIS	Jan 10, 2025
EP4175619	Compositions, Methods And Systems For Aerosol Drug Delivery	ASTRAZENECA PHARMACEUTICALS LP	Jan 9, 2025
EP4175620	Compositions, Methods And Systems For Aerosol Drug Delivery	ASTRAZENECA PHARMACEUTICALS LP	Jan 9, 2025
EP3150200	Pharmaceutical Composition, Pharmaceutical Dosage Form, Process For Their Preparation, Methods For Treating And Uses Thereof	BOEHRINGER INGELHEIM	Jan 8, 2025

Top companies who are the clients of Elkington And Fife

Company	Total
GENERICS UK	114
ELKINGTON AND FIFE	69
SANDOZ	32
SOCIETE DES PRODUITS NESTLE	26
THE PROCTER & GAMBLE	25
COOKE	23
TEVA PHARMACEUTICAL INDUSTRIES	19
TEVA UK	16
ZAKLADY FARMACEUTYCZNE POLPHARMA	13
SANOFI	10